Peroxisome proliferator-activated receptor-γ agonist rosiglitazone reduces circulating platelet activity in patients without diabetes mellitus who have coronary artery disease
Jagdip S Sidhu, Dahlia Cowan, Jennifer A Tooze, Juan-Carlos KaskiVolume:
147
Year:
2004
Language:
english
Pages:
1038
DOI:
10.1016/j.ahj.2003.12.035
File:
PDF, 139 KB
english, 2004